• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

purduepharma

FDA approves first opioid overdose reversal auto-injector from Purdue Pharma

August 8, 2024 By Sean Whooley

Purdue Pharma Logo

Purdue Pharma announced that the FDA approved its new drug application (NDA) for the Zurnai (nalmefene injection) auto-injector. The single-dose auto-injector delivers 1.5 mg of nalmefene hydrochloride per actuation. It marks the approved first nalmefene hydrochloride auto-injector for the emergency treatment of known or suspected opioid overdose. The agency approved the first nasal spray formulation […]

Filed Under: Auto-injectors, Drug-Device Combinations, Food & Drug Administration (FDA), Pharmaceuticals Tagged With: FDA, purduepharma

Purdue acquires non-opioid painkiller with SpineThera purchase

October 23, 2018 By Sarah Faulkner

Purdue Pharma

Purdue Pharma announced today that it acquired SpineThera and a dexamethasone epidural product designed to treat low back pain. SpineThera’s SX600 therapy features tiny, biodegradable microspheres which enable sustained-release of dexamethasone. “We are pleased to partner with SpineThera to support further development of its novel steroid product for epidural injection for patients who suffer from […]

Filed Under: Featured, Mergers & Acquisitions, Pain Management, Pharmaceuticals, Wall Street Beat Tagged With: purduepharma, spinethera

South Carolina becomes latest state to sue opioid-maker Purdue

August 18, 2017 By Sarah Faulkner

gavel

On Tuesday this week, South Carolina became the latest state to sue Purdue Pharma, accusing the drugmaker of deceptively marketing their addictive products in a way that fueled the ongoing opioid crisis. The state’s attorney general said that Purdue told doctors that opioids are not addictive and patients who appear to be addicted were only […]

Filed Under: Featured, Legal News, Pain Management, Pharmaceuticals, Wall Street Beat Tagged With: purduepharma

BioDelivery Sciences, Purdue ink exclusive distribution deal for Belbuca in Canada

July 12, 2017 By Sarah Faulkner

BioDelivery Sciences International

BioDelivery Sciences International (NSDQ:BDSI) said today that it inked an exclusive distribution deal with Purdue Pharma‘s Canada branch for the licensing, distribution, marketing and sale of Belbuca in Canada. The company’s Belbuca buccal film was designed to deliver buprenorphine for patients with chronic pain. It was cleared by Health Canada in June for patients with pain severe […]

Filed Under: Drug-Device Combinations, Featured, Pain Management, Pharmaceuticals, Wall Street Beat Tagged With: BioDelivery Sciences International, purduepharma

Critics allege misleading campaigns, poorly-cited data fueled opioid addiction crisis

June 2, 2017 By Sarah Faulkner

Pills

The state of Ohio filed a lawsuit against opioid-makers this week, alleging that the companies produced misleading marketing schemes to convince doctors and patients that opioids were not addictive. Ohio isn’t alone – Mississippi and West Virginia have filed similar cases against major players in the pharmaceutical industry. Purdue Pharma, Johnson & Johnson (NYSE:JNJ), Endo […]

Filed Under: Featured, Legal News, Pain Management, Pharmaceuticals, Wall Street Beat Tagged With: Endo Pharmaceuticals, johnsonandjohnson, purduepharma, Teva Pharmaceuticals

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS